The potential role of haloperidol in the treatment of trichotillomania

Journal of Affective Disorders

Volumn 56, Issue 2-3, 1999, Pages 219-226

  Van Ameringen, Michael ^a   Mancini, Catherine ^a   Oakman, Jonathan M ^b   Farvolden, Peter ^c  

^a Anxiety Disorders Clinic   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

^c HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Obsessive compulsive spectrum; Tics; Tourette Syndrome; Trichotillomania

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; LORAZEPAM; PAROXETINE; PIMOZIDE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DEPRESSION; DISEASE CLASSIFICATION; DRUG EFFICACY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; OBSESSION; PRIORITY JOURNAL; PSYCHOTHERAPY; RESTLESSNESS; SEDATION; TACHYCARDIA; TRICHOTILLOMANIA;

ADULT; ANTI-DYSKINESIA AGENTS; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; TOURETTE SYNDROME; TREATMENT OUTCOME; TRICHOTILLOMANIA;

EID: 0033381685     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(99)00019-1     Document Type: Article

References (51)

1. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Press, Washington, DC.
2. Baer L. Factor analysis of symptom subtypes of obsessive-compulsive disorder and their relation to personality and tic disorders. J. Clin. Psychiatry. 55:(3, Suppl.):1994;18-23.
3. Black D.W., Blum N. Trichotillomania treated with clomipramine and a topical steroid (letter). Am. J. Psychiatry. 149:1992;842-843.
4. Christenson G.A., Mackenzie T.B., Mitchell J.E. Characteristics of 60 adult chronic hair pullers. Am. J. Psychiatry. 148:1991;365-370.
5. Christenson G.A., Mackenzie T.B., Mitchell J.E., et al. A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. Am. J. Psychiatry. 148:1991;1566-1571.
6. Christenson G.A., Pyle R.L., Mitchell J.E. Estimated lifetime prevalence of trichotillomania in college students. J. Clin. Psychiatry. 52:1991;415-417.
7. Christenson, G.A., Crow, S.J., Mitchell, J.E. et al., 1998. Fluvoxamine in the treatment of trichotillomania: an 8-week, open-label study. CME Reviews. Available at URL http://cme-reviews.com.
8. Cohen L.J., Stein D., Simeon D., et al. Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study. J. Clin. Psychiatry. 56:1995;319-326.
9. Comings D.E. Tourette Syndrome and Human Behavior. 1990;Hope Press, Duarte, CA.
10. Erenberg G. Treatment of Tourette Syndrome with neuroleptic drugs. Chase T.N., Friedhoff A.J., Cohen D.J. Advances in Neurology. 58:1992;Raven Press, New York.
11. George M.S., Trimble M.R., Ring H.A., et al. Obsessions in obsessive-compulsive disorder with and without Gilles de la Tourette's Syndrome. Am. J. Psychiatry. 150:1993;93-97.
12. Goodman W.K., McDougle C.J., Price L.H., et al. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive-compulsive disorder. J. Clin. Psychiatry. 51:1990;36-43.
13. Goodman W.K., Price L.H., Rasmussen S.A., et al. Efficacy of fluvoxamine in obsessive-compulsive disorder: a double-blind comparison with placebo. Arch. Gen. Psychiatry. 46:1989;36-44.
14. Goodman W.K., Price L.H., Rasmussen S.A., et al. The Yale-Brown obsessive compulsive scale 1. Development, use, and reliability. Arch. Gen. Psychiatry. 46:1989;1006-1011.
15. Hollander E. Obsessive-compulsive spectrum disorders: an overview. Psychiatr. Ann. 23:(7):1993;355-358.
16. Hollander E., Benzaquen S.D. The obsessive-compulsive spectrum disorders. Int. Rev. Psychiatry. 1997;99-109.
17. Jarry J.L., Vaccarino F.J. Eating disorder and obsessive-compulsive disorder: neurochemical phenomenological commonalities. J. Psychiatry Neurosci. 21:(1):1996;36-48.
18. Jenike M.A., Baer L., Summergrad P., et al. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 30 patients. Am. J. Psychiatry. 146:1989;1328-1330.
19. Jenike M.A., Hyman S., Baer L., et al. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. Am. J. Psychiatry. 147:1990;1209-1215.
20. Koran L.M., Ringold A., Hewlett W. Fluoxetine for trichotillomania: an open clinical trial. Psychopharmacol. Bull. 28:1992;145-149.
21. Krishnan K.R.R., Davidson J.R.T., Guajardo C. Trichotillomania: a review. Compr. Psychiatry. 26:1985;123-128.
22. McDougle C.J., Goodman W.K., Price J.H., et al. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am. J. Psychiatry. 147:1990;652-654.
23. McDougle C.J., Goodman W.K., Leckman J.F., et al. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind, placebo-controlled study in patients with and without tics. Arch. Gen. Psychiatry. 51:1994;302-308.
24. Miguel E.C., Coffey B.J., Baer L., et al. Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's disorder. J. Clin. Psychiatry. 56:1995;246-255.
25. Miguel E.C., Baer L., Coffey B.J., et al. Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's syndrome. Br. J. Psychiatry. 170:1997;104-145.
26. Ninan P.T., Knight B., Kirk L., et al. A controlled trial of venlafaxine in TTM: interim phase 1 results. Psychopharmacol. Bull. 34:1998;221-224.
27. Ninan, P.T., Mansueto, C., Rothbaum, B.O. et al., 1998b. Challenges in the classification and treatment of trichotillomania. CME Reviews. Available at URL http://cme-reviews.com.
28. Muller S.A. Trichotillomania. Dermatol. Clin. 5:1987;595-601.
29. Rasmussen S., Eisen J.L. Phenomenology of OCD: clinical subtypes, heterogeneity and coexistence. Zohar J., Insel I., Rasmussen S. The Psychobiology of Obsessive-compulsive Disorder. 1991;13-43 Springer, New York.
30. Ross M.S., Moldofsky H.A. Comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome. Am. J. Psychiatry. 135:1978;585-587.
31. Shapiro A.K., Shapiro E. Treatment of Gilles de la Tourette's syndrome with haloperidol. Br. J. Psychiatry. 114:1968;345-350.
32. Shapiro A.K., Shapiro E.S. The treatment and etiology of tics and Tourette's syndrome. Compr. Psychiatry. 22:1981;193-205.
33. Shapiro A.K., Shapiro E. Evaluation of the reported association of obsessive-compulsive symptoms or disorder with Tourette's disorder. Compr. Psychiatry. 33:1992;152-165.
34. Shapiro A.K., Shapiro E., Young J.G., et al. Gilles de la Tourette Syndrome. 2nd :1988;Raven Press, New York.
35. Shapiro E., Shapiro A.K. Tardive dyskinesia and chronic neuroleptic treatment of tourette patients. Friedhoff A.J., Chase T.N. Gilles De La Tourette Syndrome. 1982;Raven Press, New York.
36. Shapiro E., Shapiro A.K., Fulop G., et al. Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome. Arch. Gen. Psychiatry. 46:1989;722-730.
37. Silva R.R., Magee H.J., Friedhoff A.J. Persistent tardive dyskinesia and other neuroleptic-related dyskinesias in Tourette's disorder. J. Child Adolesc. Psychopharmacol. 3:1993;137-144.
38. Silva R.R., Muňoz D.M., Daniel W., et al. Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives. J. Clin. Psychiatry. 57:1996;129-135.
39. Spitzer R.L., Williams J.B.W., Gibbon M. Instruction Manual for the Structured Clinical Interview for DSM-III-R (SCID, 4/1/87 Revision. 1987;Biometrics Research Department, New York State Psychiatric Institute, New York.
40. Stahl S.M. Not so selective serotonin reuptake inhibitors. J. Clin. Psychiatry. 59:(7):1998;343-344.
41. Stanley M.A., Breckenridge J.K., Swann A.C., et al. Fluvoxamine treatment of trichotillomania. J. Clin. Psychopharmacol. 17:(4):1996;278-283.
42. Stein D.J., Hollander E. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J. Clin. Psychiatry. 53:1992;123-126.
43. Stein D.J., Brouwer M.B., Maud X. Use of the selective serotonin reuptake inhibitor citalopram in the treatment of trichotillomania. Eur. Arch. Psychiatry Clin. Neurosci. 247:1997;234-236.
44. Stein, D.J., O'Sullivan, R.L., van Heerden, B. et al., 1998. The neurobiology of trichotillomania.CNS Spectrums. CME Reviews. Available at URL http://cme-reviews.com.
45. Streichenwein S.M., Thornby J.I. A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. Am. J. Psychiatry. 152:1995;1192-1196.
46. Swedo S.E., Leonard H.L. Trichotillomania: an obsessive-compulsive spectrum disorder? Psychiatr. Clin. North Am. 15:(4):1992;777-790.
47. Swedo S.E., Leonard H.L., Rapoport J.L., et al. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania. N. Engl. J. Med. 321:1989;497-500.
48. The Tourette Syndrome Classification Study Group, 1993. Definitions and classification of tic disorders. Arch. Neurol. 50, 1013-1016.
49. Turner S.M., Beidel D.C., Himmelhoch J., et al. Fluoxetine treatment of obsessive-compulsive disorder. J. Clin. Psychopharmacol. 5:1985;207-212.
50. Winchel R.M., Jones S., Stanley B., et al. Clinical characteristics of trichotillomania and its response to fluoxetine. J. Clin. Psychiatry. 53:1992;304-308.
51. Yanchick J.K., Barton T.L., Kelly M.W. Efficacy of fluoxetine in trichotillomania. Ann. Pharmacother. 28:1994;1245-1246.